Dow JonesNov 6, 2024 01:51· Ratings Goldman Sachs Maintains Neutral on TG Therapeutics, Raises Price Target to $22 BenzingaNov 6, 2024 01:26· Ratings A Quick Look at Today's Ratings for TG Therapeutics(TGTX.US), With a Forecast Between $38 to $55 Futu NewsNov 5, 2024 21:00· ...
Nov 13, 2024 06:08 TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N Nov 13, 2024 06:05 TG Therapeutics | 144/A: Others Nov 13, 2024 01:54 TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 Nov 13...